Prolonged survival after bevacizumab rechallenge in glioblastoma patients with previous response to bevacizumab(†)
既往对贝伐单抗有反应的胶质母细胞瘤患者再次接受贝伐单抗治疗后生存期延长(†)
期刊:Neuro-Oncology Practice
影响因子:2.5
doi:10.1093/nop/npw004
Balaña, Carmen; Estival, Anna; Pineda, Estela; Sepúlveda, Juan; Mesía, Carles; Del Barco, Sonia; Gil-Gil, Miguel; Hardy, Max; Indacoechea, Alberto; Cardona, Andrés Felipe
